Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome

被引:93
|
作者
Lien, Lillian F.
Brown, Ann J.
Ard, Jamy D.
Loria, Catherine
Erlinger, Thomas P.
Feldstein, Adrianne C.
Lin, Pao-Hwa
Champagne, Catherine M.
King, Abby C.
McGuire, Heather L.
Stevens, Victor J.
Brantley, Phillip J.
Harsha, David W.
McBurnie, Mary Ann
Appel, Lawrence J.
Svetkey, Laura P.
机构
[1] Duke Univ, Med Ctr, Div Endocrinol Metab & Nutr, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Duke Hypertens Ctr, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Div Nephrol, Dept Med, Durham, NC 27710 USA
[4] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA
[5] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA
[6] NHLBI, NIH, Bethesda, MD 20892 USA
[7] Univ Texas, Med Branch, Austin, TX 78712 USA
[8] Kaiser Permanente Ctr Hlth Res, Portland, OR USA
[9] Pennington Biomed Res Ctr, Baton Rouge, LA USA
[10] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
[11] Johns Hopkins Med Inst, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA
关键词
hypertension; metabolic syndrome; insulin resistance; lifestyle modification; DASH;
D O I
10.1161/HYPERTENSIONAHA.107.089458
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Lifestyle modification can reduce blood pressure and lower cardiovascular risk. Established recommendations include weight loss, sodium reduction, and increased physical activity. PREMIER studied the effects of lifestyle interventions based on established recommendations alone and with the addition of the Dietary Approaches to Stop Hypertension (DASH) dietary pattern. This analysis aimed to assess the interventions' impact on cardiometabolic variables in participants with, compared with those without, metabolic syndrome. The primary outcome was 6-month change in systolic blood pressure. Participants with prehypertension or stage-1 hypertension were randomly assigned to an advice only control group, a 6-month intensive behavioral intervention group of established recommendations (EST), or an established recommendations plus DASH group (EST + DASH). Metabolic syndrome was defined per National Cholesterol and Education Program Adult Treatment Panel III. We used general linear models to test intervention effects on change in blood pressure, lipids, and insulin resistance (homeostasis model assessment), in subgroups defined by the presence or absence of metabolic syndrome. Of 796 participants, 399 had metabolic syndrome. Both EST and EST + DASH reduced the primary outcome variable, systolic blood pressure. Within the EST + DASH group, those with and without metabolic syndrome responded similarly (P = 0.231). However, within EST, those with metabolic syndrome had a poorer response, with a decrease in systolic blood pressure of 8.4 mm Hg versus 12.0 mm Hg in those without metabolic syndrome (P = 0.002). Thus, metabolic syndrome attenuated the systolic blood pressure reduction of EST, but this attenuation was overcome in EST + DASH. Finally, diastolic blood pressure, lipids, and homeostasis model assessment responded similarly to both interventions regardless of metabolic syndrome status. Our data suggest that strategies for lowering BP in individuals with metabolic syndrome may be enhanced by recommendations to adopt the DASH dietary pattern.
引用
收藏
页码:609 / 616
页数:8
相关论文
共 50 条
  • [1] METABOLIC BENEFITS OF LIFESTYLE MODIFICATIONS IN PATIENTS WITH METABOLIC SYNDROME
    Gkogkos, K.
    Miggos, C.
    Siarkou, O.
    Nikitidou, O.
    Panara, E.
    Pavlidis, G.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 66 - 66
  • [2] Metabolic syndrome guidelines center on lifestyle modifications
    不详
    [J]. GERIATRICS, 2006, 61 (03) : 14 - +
  • [3] Metabolic syndrome. Endothelial impact of lifestyle modifications
    Fabregate, R.
    Sanchez, O.
    Fabregate, M.
    Redondo, S.
    De La Torre, N.
    Saban-Ruiz, J.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 179 - 179
  • [4] Endothelial impact of sequential lifestyle modifications in patients with metabolic syndrome
    Fabregate, R
    Fabregate, M
    Marquez, J
    Calbacho, M
    Ugalde, A
    Sabán-Ruiz, J
    [J]. DIABETOLOGIA, 2005, 48 : A421 - A421
  • [5] Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome in Women: Effects of Lifestyle Modifications
    Guagnano, Maria Teresa
    D'Ardes, Damiano
    Ilaria, Rossi
    Santilli, Francesca
    Schiavone, Cosima
    Bucci, Marco
    Cipollone, Francesco
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (10)
  • [6] Actively incorporating lifestyle modifications into daily life: The key to adherence in a lifestyle intervention programme for metabolic syndrome
    Wang, Qun
    Chair, Sek Ying
    Wong, Eliza Mi Ling
    Qiu, Xichenhui
    [J]. FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [7] Effects of the "PreveDi" lifestyle modification trial on metabolic syndrome
    Villarini, Milena
    Lanari, Chiara
    Barchiesi, Luisa
    Casciari, Elisa
    Tabascio, Antonio
    Castellini, Monica
    Levorato, Sara
    Vannini, Samuele
    Fornaciari, Giuseppe
    Moretti, Massimo
    Villarini, Anna
    [J]. ANNALI DI IGIENE MEDICINA PREVENTIVA E DI COMUNITA, 2015, 27 (03): : 595 - 606
  • [8] Discrepant social economic status and lifestyle in subjects with and without metabolic syndrome
    Liu, DY
    Yu, ZP
    Zhang, G
    Zhu, ZM
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 146A - 146A
  • [9] Modifiable lifestyle factors and the metabolic syndrome in older men: Effects of lifestyle changes
    Wannamethee, S. Goya
    Shaper, A. Gerald
    Whincup, Peter H.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (12) : 1909 - 1914
  • [10] Effects of Synbiotic Supplementation and Lifestyle Modifications on Women With Polycystic Ovary Syndrome
    Chudzicka-Strugala, Izabela
    Kubiak, Anna
    Banaszewska, Beata
    Zwozdziak, Barbara
    Siakowska, Martyna
    Pawelczyk, Leszek
    Duleba, Antoni J.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (09): : 2566 - 2573